Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kjaja
    Member
    • Aug 2011
    • 58

    #1

    analyzing RNA seq

    Hi All,

    I have RNA sequencing data (expression data) for a control sample and cases (with disease) and at multiple time points but no replicates of. any ideas on how to analyze this type of data?

    thanks
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    check out Deseq2 and Dexseq.

    Comment

    • crazyhottommy
      Senior Member
      • Apr 2012
      • 187

      #3
      No replicates is a bad experimental design.
      Next maSigPro: updating maSigPro Bioconductor
      package for RNA-seq time series

      and here http://www.hindawi.com/journals/bmri/2013/203681/

      Comment

      • mbblack
        Senior Member
        • Aug 2009
        • 245

        #4
        No replicates means you have no ability to use parametric statistics to assess significance (other than using permutations or some other iterative approach to simulate=guestimate variance).

        You should have a look at some alternative analysis. Two that come to mind is a simple Rank Product analysis of fold change lists (which you can do in R or in a simple Excel spreadsheet for that matter). There is also GFOLD (http://bioinformatics.oxfordjournals...8/21/2782.long ) which uses a baseyian posterior probablity estimate of the distribution of fold changes to derive statistics and ranking. GFOLD will be helped by replicates (as they allow for a more robust estimate of the posterior probability distribution) but is valid without them (the only assumption then is that read count for any gene is poisson distributed).

        GFOLD is available in BioConductor.
        Last edited by mbblack; 07-31-2014, 06:41 AM.
        Michael Black, Ph.D.
        ScitoVation LLC. RTP, N.C.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...